Resources for Food and Drug Administration (FDA)

Constant Glucose Monitoring System Gains FDA Approval, Abbott Says

online.wsj.com

Abbott Laboratories Inc. has received Food and Drug Administration approval for a continuous glucose-monitoring system that allows constant tracking of blood-sugar levels to help diabetes patients manage the disease.

The FreeStyle Navigator system works through a sensor placed in the back of the upper arm or abdomen, and a transmitter that sends wireless information to a receiver device that is the size of a pager.

It will be available by prescription starting in the second quarter. The system was approved in Europe last June and has been available outside the U.S. since September.

View the Resource

Share or bookmarklet this web page at: